Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio Expands Operations in Response to Increased Data Analysis Demands in the Americas

Premium

CLC Bio announced this week that it has opened two new offices in Boston and in the Washington DC area to meet the increasing demand for its data analysis tools from customers in North and South America.

The company's Boston office officially opened on Sept. 1 and will be a home base for its sales, marketing, and support operations. The DC-based offices will be used as a Government Sector branch.

CLC Bio has also hired several new employees this year and plans to employ additional staff for its US team.

In a statement, Saul Kravitz, CLC Bio's director of North American Consulting Services said that the new offices provide "a strong base" to support the company's growing list of customers.

Earlier this month, in a similar effort to expand its footprint in Asia, CLC Bio announced that it was partnering with Japanese informatics company, World Fusion to create a high-throughput sequence analysis service center in Japan. (BI 08/20/2010)

In 2009, CLC Bio posted a 130 percent increase in sales globally and a 200 percent growth rate in isolated Americas sales for the same period.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.